
- Articles
PING 2024 round-up - 'AI in pharma - Threat or opportunity?'
16 Jul 2024Over a month has passed since the 2024 PING conference, providing invaluable insights into the uptake of AI in Pharma, its transformational promise, and the accompanying risks and pitfalls. Below is a summary of our key takeaways.

- Articles
PING Conference 2025 - Key takeaways
19 Jun 2025This paper is part of our Sustainability Insights series following the 2025 PING Conference on Sustainability - What must Pharma do now? - bringing you expert perspectives and practical takeaways from key discussions shaping the future of businesses looking to address the threats and opportunities of sustainability in the life sciences sector. Thanks to Hertfordshire Futures for their great support of PING yet again.

- Articles
Can I use covert recordings in family court proceedings?
21 Aug 2025After much anticipation, the Family Justice Council (FJC) has now formalised their important guidance on the use of covert recordings in family law proceedings. Covert recordings are those made without the knowledge or consent of the person being recorded.

- Articles
NICE and MHRA work closer to deliver innovative medicines faster
11 Aug 2025In the recent Life Sciences Sector Plan, one of the promises to make the UK the third best place in the world for life sciences was to streamline regulation and market access.

- Articles
Concussions in rugby: Why Garry Ringrose put safety first
31 Jul 2025Head injuries in rugby, and many other sports, are a serious concern, and recognising the signs early can make all the difference in preventing long-term consequences.

- Articles
UK leads the way on personalised medicine with new decentralised manufacturing legislation
01 Aug 2025The UK has taken a massive step forward in the holy grail of personalised medicine by introducing new regulations that enable treatments to be prepared and delivered directly at the point of care.